| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Submitted on July 11, 2003
Accepted on July 30, 2003
From the Dyslipoproteinemia and Atherosclerosis Research Unit (U.551), National Institute for Health and Medical Research (INSERM), Hôpital de la Pitié, Paris, France.
* To whom correspondence should be addressed. E-mail: kontush{at}chups.jussieu.fr.
Objectives--The relationship of the structural and functional heterogeneity of HDL particles to protection of LDL against oxidative stress is indeterminate.
Methods and Results--HDL subfractions of defined physicochemical properties were isolated by density gradient ultracentrifugation from normolipidemic human serum (n=8), and their capacity to protect LDL from oxidation was evaluated. Under mild oxidative stress induced by AAPH or Cu(II), HDL subfractions (at equal cholesterol or protein concentration or equal particle number) significantly decreased LDL oxidation rate (-10% to -64%) in the propagation phase (234 nm), which was prolonged by up to 82% with decreased maximal diene formation. Antioxidative activity of HDL subfractions increased with increment in density, as follows: HDL2b<HDL2a<HDL3a<HDL3b<HDL3c (confirmed by TBARS content and LDL electrophoretic mobility). Concordantly, antioxidative activity of small HDL prepared by FPLC was significantly higher (+56%) than that of large HDL. Antioxidative action of HDL subfractions was primarily associated with inactivation of LDL lipid hydroperoxides. The potent protective activity of small HDL could not be accounted for exclusively by enzymatic activities (PON1, platelet-activating factor acetylhydrolase, and lecithin-cholesterol acyltransferase).
Conclusions--Small, dense HDL exhibit potent antioxidant activity, which may arise from synergy in inactivation of oxidized LDL lipids by enzymatic and nonenzymatic mechanisms, in part reflecting distinct intrinsic physicochemical properties.
This article has been cited by other articles:
![]() |
W. S. Davidson, R.A. G. D. Silva, S. Chantepie, W. R. Lagor, M. J. Chapman, and A. Kontush Proteomic Analysis of Defined HDL Subpopulations Reveals Particle-Specific Protein Clusters: Relevance to Antioxidative Function Arterioscler Thromb Vasc Biol, June 1, 2009; 29(6): 870 - 876. [Abstract] [Full Text] [PDF] |
||||
![]() |
K.-A. Rye, C. A. Bursill, G. Lambert, F. Tabet, and P. J. Barter The metabolism and anti-atherogenic properties of HDL J. Lipid Res., April 1, 2009; 50(Supplement): S195 - S200. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. El Harchaoui, B. J. Arsenault, R. Franssen, J.-P. Despres, G. K. Hovingh, E. S.G. Stroes, J. D. Otvos, N. J. Wareham, J. J.P. Kastelein, K.-T. Khaw, et al. High-Density Lipoprotein Particle Size and Concentration and Coronary Risk Ann Intern Med, January 20, 2009; 150(2): 84 - 93. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Juarez-Rojas, A. Medina-Urrutia, R Posadas-Sanchez, E Jorge-Galarza, E Mendoza-Perez, N Caracas-Portilla, G Cardoso-Saldana, G Munoz-Gallegos, and C Posadas-Romero High-density lipoproteins are abnormal in young women with uncomplicated systemic lupus erythematosus Lupus, November 1, 2008; 17(11): 981 - 987. [Abstract] [PDF] |
||||
![]() |
R. A. G. D. Silva, R. Huang, J. Morris, J. Fang, E. O. Gracheva, G. Ren, A. Kontush, W. G. Jerome, K.-A. Rye, and W. S. Davidson Structure of apolipoprotein A-I in spherical high density lipoproteins of different sizes PNAS, August 26, 2008; 105(34): 12176 - 12181. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Guha, D. L. Gantz, and O. Gursky Effects of acyl chain length, unsaturation, and pH on thermal stability of model discoidal HDLs J. Lipid Res., August 1, 2008; 49(8): 1752 - 1761. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Kontush and M. J. Chapman HDL: Close to Our Memories? Arterioscler Thromb Vasc Biol, August 1, 2008; 28(8): 1418 - 1420. [Full Text] [PDF] |
||||
![]() |
W. A. van der Steeg, I. Holme, S. M. Boekholdt, M. L. Larsen, C. Lindahl, E. S.G. Stroes, M. J. Tikkanen, N. J. Wareham, O. Faergeman, A. G. Olsson, et al. High-density lipoprotein cholesterol, high-density lipoprotein particle size, and apolipoprotein A-I: significance for cardiovascular risk: the IDEAL and EPIC-Norfolk studies. J. Am. Coll. Cardiol., February 12, 2008; 51(6): 634 - 642. [Abstract] [Full Text] [PDF] |
||||
![]() |
M J. Chapman Metabolic syndrome and type 2 diabetes: lipid and physiological consequences Diabetes and Vascular Disease Research, September 1, 2007; 4(3_suppl): S5 - S8. [Abstract] [PDF] |
||||
![]() |
A. Kontush, P. Therond, A. Zerrad, M. Couturier, A. Negre-Salvayre, J. A. de Souza, S. Chantepie, and M. J. Chapman Preferential Sphingosine-1-Phosphate Enrichment and Sphingomyelin Depletion Are Key Features of Small Dense HDL3 Particles: Relevance to Antiapoptotic and Antioxidative Activities Arterioscler Thromb Vasc Biol, August 1, 2007; 27(8): 1843 - 1849. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. A. Morehouse, E. D. Sugarman, P.-A. Bourassa, T. M. Sand, F. Zimetti, F. Gao, G. H. Rothblat, and A. J. Milici Inhibition of CETP activity by torcetrapib reduces susceptibility to diet-induced atherosclerosis in New Zealand White rabbits J. Lipid Res., June 1, 2007; 48(6): 1263 - 1272. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Thomas-Moya, M. Gianotti, A. M. Proenza, and I. Llado The age-related paraoxonase 1 response is altered by long-term caloric restriction in male and female rats J. Lipid Res., September 1, 2006; 47(9): 2042 - 2048. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Kontush and M. J. Chapman Functionally Defective High-Density Lipoprotein: A New Therapeutic Target at the Crossroads of Dyslipidemia, Inflammation, and Atherosclerosis Pharmacol. Rev., September 1, 2006; 58(3): 342 - 374. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. H.E.M. Klerkx, K. E. Harchaoui, W. A. van der Steeg, S. M. Boekholdt, E. S.G. Stroes, J. J.P. Kastelein, and J. A. Kuivenhoven Cholesteryl Ester Transfer Protein (CETP) Inhibition Beyond Raising High-Density Lipoprotein Cholesterol Levels: Pathways by Which Modulation of CETP Activity May Alter Atherogenesis Arterioscler Thromb Vasc Biol, April 1, 2006; 26(4): 706 - 715. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. L. Rainwater, M. C. Mahaney, X. L. Wang, J. Rogers, L. A. Cox, and J. L. VandeBerg Determinants of variation in serum paraoxonase enzyme activity in baboons J. Lipid Res., July 1, 2005; 46(7): 1450 - 1456. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. F. Teiber, D. I. Draganov, and B. N. La Du Purified human serum PON1 does not protect LDL against oxidation in the in vitro assays initiated with copper or AAPH J. Lipid Res., December 1, 2004; 45(12): 2260 - 2268. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Hansel, P. Giral, E. Nobecourt, S. Chantepie, E. Bruckert, M. J. Chapman, and A. Kontush Metabolic Syndrome Is Associated with Elevated Oxidative Stress and Dysfunctional Dense High-Density Lipoprotein Particles Displaying Impaired Antioxidative Activity J. Clin. Endocrinol. Metab., October 1, 2004; 89(10): 4963 - 4971. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. W. Kent Jr, A. G. Comuzzie, M. C. Mahaney, L. Almasy, D. L. Rainwater, J. L. VandeBerg, J. W. MacCluer, and J. Blangero Intercellular Adhesion Molecule-1 Concentration Is Genetically Correlated With Insulin Resistance, Obesity, and HDL Concentration in Mexican Americans Diabetes, October 1, 2004; 53(10): 2691 - 2695. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Kontush, M. J. Chapman, and R. Stocker Vitamin E Is Not Deficient in Human Atherosclerotic Plaques Arterioscler Thromb Vasc Biol, July 1, 2004; 24(7): e139 - e140. [Full Text] [PDF] |
||||
![]() |
H. Kim, E. L. Jacobson, M. K. Jacobson, and A. G. Lacko ApoA-1 Milano and Regression of Atherosclerosis JAMA, March 17, 2004; 291(11): 1319 - 1319. [Full Text] [PDF] |
||||
![]() |
A. Kontush, E. C. de Faria, S. Chantepie, and M. J. Chapman Antioxidative Activity of HDL Particle Subspecies Is Impaired in Hyperalphalipoproteinemia: Relevance of Enzymatic and Physicochemical Properties Arterioscler Thromb Vasc Biol, March 1, 2004; 24(3): 526 - 533. [Abstract] [Full Text] |
||||
|
ATVB Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2003 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |